Showing 6491-6500 of 8649 results for "".
- Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR Implanthttps://modernod.com/news/allergan-announces-positive-topline-phase-3-clinical-data-for-bimatoprost-sr-implant/2480095/Allergan announced the release of new topline clinical trial data on Bimatoprost SR, a sustained-release, biodegradable implant for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension. Bim
- GenSight Biologics Reports Positive Additional Data From REVERSE Phase 3 Clinical Trial of GS010 for Treatment of LHONhttps://modernod.com/news/gensight-biologics-reports-positive-additional-data-from-reverse-phase-3-clinical-trial-of-gs010-for-treatment-of-leber-hereditary-optic-neuropathy-lhon/2480100/GenSight Biologics reported additional results from the REVERSE phase 3 clinical trial evaluating the safety and efficacy of a single intravitreal injection of GS010 (rAAV2/2-ND4)in patients with Leber Hereditary Optic Neuropathy (LHON). The study involved 37 patients with visual loss du
- CMS Issues Preliminary Decision on Unique J Code for Avedro Photrexa Drug Formulationshttps://modernod.com/news/cms-issues-preliminary-decision-on-unique-j-code-for-avedro-photrexa-drug-formulations/2480101/Avedro announced that the Centers for Medicare and Medicaid Services (CMS) has issued a preliminary decision to establish a product specific Healthcare Common Procedure Coding System (HCPCS) J code for Photrexa drug formulations. Claims submitted with a product specific J code are generally proce
- Optovue Receives FDA Clearance for AngioAnalytics – the First OCT Angiography Metrics Technologyhttps://modernod.com/news/optovue-receives-fda-clearance-for-angioanalytics-the-first-oct-angiography-metrics-technology/2480103/Optovue announced FDA 510(k) clearance of AngioAnalytics, the first optical coherence tomography angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness. The company also received clearance for its three-dimensional projection art
- New Data: Physicians Experience Highest Suicide Rate of Any Professionhttps://modernod.com/news/new-data-physicians-experience-highest-suicide-rate-of-any-profession/2480104/With one completed suicide every day, US physicians have the highest suicide rate of any profession. In addition, the number of physician suicides is more than twice that of the general population, new research shows, according to a
- EyeSouth Announces Strategic Partnership with South Georgia/North Florida Eye Partnershttps://modernod.com/news/eyesouth-announces-strategic-partnership-with-south-georgia-north-florida-eye-partners/2480107/EyeSouth Partners has completed a strategic partnership with South Georgia/North Florida Eye Partners, and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions. EyeSouth is an eye care-focused physician services organization f
- Ophthalmologists Issue Eye Safety Warning Ahead of Fireworkshttps://modernod.com/news/ophthalmologists-issue-eye-safety-warning-ahead-of-fireworks-severy-year-about-10000-people-are-rushed-to-the-emergency-department-for-fireworks-injuries-ophthalmologists-physicians-who-s/2480108/Every year, about 10,000 people are rushed to the emergency department for fireworks injuries. Ophthalmologists treat thousands of patients who suffer a range of fireworks-related injuries, from cuts and bruises to damaged corneas, retinas, and ruptured eyeballs. Many people believe that consumer
- Eyenovia Receives Notices of Allowance from USPTO on Two Additional Patent Applications for Ophthalmic Drug Deliveryhttps://modernod.com/news/eyenovia-receives-notices-of-allowance-from-uspto-on-two-additional-patent-applications-for-ophthalmic-drug-delivery/2480109/Eyenovia announced it has received Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for two additional patent applications. The allowed patents provide fundamental coverage on physiologic microdroplet ejection diameters and velocities, which enable gentle delivery of ophthal
- Coburn Technologies Announces New Location for Corporate Headquartershttps://modernod.com/news/coburn-technologies-announces-new-location-for-corporate-headquarters/2480113/Coburn Technologies announced the relocation of their corporate headquarters to a newly renovated, modern facility in South Windsor, Connecticut. Effective July 23, 2018, Coburn Technologies will operate from their new location – 83 Gerber Road West, South Windsor, Connecticut, 06074.
- Allergan Shareholders Urge Company to Overhaul Management Structure; Split Role of Chairman and CEOhttps://modernod.com/news/allergan-shareholders-urge-company-to-overhaul-management-structure-split-role-of-chairman-and-ceo/2480116/In a letter sent to Allergan’s board of directors on Tuesday, two company shareholders, Appaloosa Management and Senator Investment Group, called on the drugmaker to divide the roles of chief executive officer and chairman, currently held by Brent Saunders. The investors also urged Allergan